Insider · CIK 0001883821
Jason Haas
Files at LGND (LIGAND PHARMACEUTICALS INC), SYRS (Syros Pharmaceuticals, Inc.). First filing Nov 20, 2024, latest Nov 20, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SYRS: Syros Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 62Notable | Syros Pharmaceuticals, Inc. | $29k 137,803 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +1,209 | $0.00 | $0 | 6,606 | Jun 10, 2025 |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +5,783 | $0.00 | $0 | 5,783 | Jun 10, 2025 |
| Nov 18, 2024 | SYRS Syros Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -137,803 | $0.21 | $29k | 0 | Nov 20, 2024 |
| Oct 31, 2024 | SYRS Syros Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +18,875 | - | - | 143,427 | Nov 4, 2024 |
| Oct 31, 2024 | SYRS Syros Pharmaceuticals, Inc. | FTax withholding Common Stock10b5-1 | -5,624 | $2.09 | $12k | 137,803 | Nov 4, 2024 |
| Oct 31, 2024 | SYRS Syros Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -18,875 | $0.00 | $0 | 0 | Nov 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.